Sherwood Park, Canada Clinical Trials

A listing of Sherwood Park, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 489 clinical trials
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

This phase II trial studies how stopping tyrosine kinase inhibitors will affect treatment-free remission in patients with chronic myeloid leukemia in chronic phase. When the level of disease is very low, it's called molecular remission. TKIs are a type of medication that help keep this level low. However, after being …

University of Alberta Hospital
 (9.4 away) Contact site
  • 12 views
  • 27 Jul, 2022
  • +87 other locations
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping) (PREMOD2FU)

An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received UCM or DCC. This prospective multi-national randomized controlled trial (RCT) is a two-arm parallel non-inferiority design of two alternative approaches of treatment.

Governors of University of Alberta
 (9.5 away) Contact site
  • 72 views
  • 23 Apr, 2022
  • +17 other locations
SAHaRA: A Randomized Controlled Trial

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.

University of Alberta Hospital
 (8.0 away) Contact site
  • 364 views
  • 02 Mar, 2022
  • +16 other locations
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)

VAY736 dose testing; VAY736 efficacy and safety testing.

adcc
Novartis Investigative Site
 (9.4 away) Contact site
  • 135 views
  • 13 Jul, 2022
  • +42 other locations
Fluids in Septic Shock (FISSH) (FISSH)

Despite evidence of the physiologic benefits and possible lower mortality associated with low chloride solutions, normal saline remains the most wildly used fluid in the world. Given uncertainty about the impact of lower chloride versus higher chloride solutions on mortality, it is unlikely that clinical practice will change without new …

Covenant Health
 (8.1 away) Contact site
  • 22 views
  • 07 Jul, 2022
  • +16 other locations
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke (EAISE)

Stroke is one of the leading causes death and major functional disability worldwide. Treatment options for acute stroke are limited with many patients having residual neurologic impairment. The purpose of this study is to evaluate the safety and efficacy of elezanumab and assess change in neurologic function in participants following …

University of Alberta Hospital - Division of Hematology /ID# 218370
 (9.4 away) Contact site
  • 29 views
  • 07 Jun, 2022
  • +35 other locations
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)

A Phase 2a, multicenter, randomized, double-blind, dose-ranging, placebo-controlled, study to evaluate the safety, tolerability, and PK of PLN-74809 in participants with primary sclerosing cholangitis and suspected liver fibrosis

fibrosis
MRI
ursodiol
endoscopic retrograde cholangiopancreatography
magnetic resonance cholangiopancreatography
University of Alberta Hospital - Walter C. Mackenzie Health Sciences Centre
 (9.4 away) Contact site
  • 33 views
  • 09 Jun, 2022
  • +52 other locations
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)

A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple Sclerosis (PPMS). All eligible participants will be randomized 1:1 to either daily oral fenebrutinib (or placebo) or intravenous (IV) ocrelizumab (or placebo) in a blinded fashion through an interactive voice …

University of Alberta Hospital
 (9.4 away) Contact site
  • 0 views
  • 14 Jul, 2022
  • +135 other locations
Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

This is an open-label, randomized, multi-center, comparator Phase II trial looking at the addition of Bevacizumab to Vinblastine in chemotherapy nave pediatric patients with progressive Low Grade Glioma aged 6 months to less than18 years of age at the time of initiation of therapy. Participants will be randomized to Arm …

BRAF
glomerular filtration rate
auditory test
corticosteroids
vinblastine
Stollery Children's Hospital
 (8.1 away) Contact site
  • 6 views
  • 27 Jan, 2022
  • +23 other locations
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Individuals receiving dialysis are at risk of heart failure and heart related death. There is an urgent need for treatments that reduce the risk of these problems in patients that require dialysis. Spironolactone is a pill used to prevent heart failure and related deaths in patients that do not require …

University of Alberta
 (9.6 away) Contact site
  • 214 views
  • 26 Jan, 2021
  • +97 other locations